Flu Medication Government Bids & RFPs

The correct closing date is Jul 31, 2026.

The offer due date is July 1, 2026, at 3:30 PM CT. Proposals must be submitted via email to ***@***. *. * and ***@***. *. * with a scanned PDF copy of the signed **** suggests that offerors submit their proposals well before the deadline and confirm receipt of all attachments with the contracting officer listed on the ****.

Payment terms are not explicitly detailed for direct payment from the government to the contractor. Instead, contractors will receive payments from the Prime Vendor (PPV) programs. Payment terms, time and place of delivery to ppv distribution centers, and other business-to-business agreement terms shall be agreed upon between the ppv contractors and the contractor awarded a contract from this solicitation.

The contract includes a warranty clause stating: The contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.

Offers will be evaluated in accordance with the policies and procedures of FAR Part 12, Part 15, and Part 25. one award will be made for line item 1 for the base year and all four option years.

Offerors must submit a price for the base year and all four option years. If the offeror is not the manufacturer, a letter of commitment from the manufacturer is required. Offerors must also provide a unique 11-digit NDC number for each offered drug. an acceptable letter of commitment is required from all distributorofferors to be eligible for award.

Failure to provide awarded product meeting all solicitation/contract requirements by the ordering period start date may result in contract termination for cause. Willful failure or refusal to furnish required reports, or falsification thereof, shall constitute sufficient cause for terminating the contract. failure to timely pay the cost recovery fee constitutes a contract debt to the united states government.

Proposals that fail to include a price for the base year and each of the four option years for line item 1 may be rejected. Offers that fail to provide a unique 11-digit NDC number may be rejected. offers of covered drugs including biologics that fall within 21 cfr **** will only be considered for award if the offeror has an executed ma and ppa which includes the proposed drug productsndcs on file with the va national acquisition center, fss in accordance with 38 u. s. c. 8126h4b.

The ordering period begins at the expiration of the implementation period. The base year ordering period will be in effect for one year. The contractor shall ensure that sufficient inventory of contract items awarded under this solicitation is available, and that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of government orders by the expiration of the contract implementation period.

Payment terms, time and place of delivery to PPV distribution centers, and other business-to-business agreement terms shall be agreed upon between the PPV contractors and the contractor awarded a contract from this solicitation. The contractor will be receiving payments from the PPV programs instead of directly from the government.

The contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.

Offers will be evaluated in accordance with the policies and procedures of FAR Part 12, Part 15, and Part 25. To be considered for award, offerors must submit a price for line item 1, for the base year and all four option years.

If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror of a source of supply sufficient to satisfy the governments requirements for the contract period.

Failure to remit the full amount of the cost recovery fee within 30 calendar days after the end of the applicable reporting period constitutes a contract debt to the United States Government. Willful failure or refusal to furnish the required reports, or falsification thereof, shall constitute sufficient cause for terminating the contract. . .

Offers that fail to provide the information required by this paragraph by the solicitations due date and time for receipt of offers may be rejected and receive no further consideration.